Key Highlights

  • Surgery Partners (NASDAQ:SGRY) led with a 72.41% one month gain, propelled by a USD 23.50 per share cash takeover, ahead of Teladoc Health at 60.31%, Ardent Health at 46.47%, Progyny at 32.25% and Acadia Healthcare at 25.75%.
  • Teladoc Health (NYSE:TDOC) is the sole small cap on the list, closing at USD 9.33 after third quarter Revenue of USD 605.1 million, adjusted EBITDA of USD 79.4 million and a net loss per share narrowed to USD 0.15.
  • Ardent Health, Inc. (NYSE:ARDT) pushed the low end of its 2026 adjusted EBITDA guidance up to USD 500 million with the top kept at USD 535 million, while Acadia Healthcare (NASDAQ:ACHC) lifted adjusted EPS guidance to USD 1.70 to USD 1.80.
  • Progyny (NASDAQ:PGNY) delivered adjusted EPS of USD 0.52 against USD 0.31 consensus and trades at USD 34.20, while Surgery Partners closed at USD 23.16, just beneath the USD 23.50 offer.

Teladoc Health (NYSE:TDOC): Profit Inflection in a Quarter With Falling Revenue

The dated trigger is third quarter reporting released October 28, 2026. Revenue slid 3% to USD 605.1 million from USD 626.4 million, yet adjusted EBITDA climbed 14% to USD 79.4 million, beating the company's own range, and net loss per share narrowed to USD 0.15 from USD 0.28. Free Cash Flow came to USD 75.9 million, compared with USD 67.9 million. Teladoc Health (NYSE:TDOC) kept rising afterward, adding 17.80% over one week to USD 9.33. The story is profitability improving rather than growth accelerating, since investors frequently accept a flat or shrinking Top Line when losses shrink and cash flow strengthens. Short covering after a drawdown can add fuel, a point that remains general context rather than a confirmed driver. Using the net loss and loss per share, about 179 million shares imply a Market Value near USD 1.7 billion (calculated). BetterHelp is the weak spot, with revenue down 13% to USD 206.6 million and guidance pointing to a fourth quarter decline of as much as 31.5%. Teladoc Health (NYSE:TDOC) still posts losses, and a few trades can shift its price.

Ardent Health, Inc. (NYSE:ARDT): A Profit Swing and a Firmer Guidance Floor

Third quarter 2026 results arrived on November 4, 2026. Net Income came in at USD 44.5 million, reversing a net loss of USD 23.5 million, while Operating Income reached USD 81 million compared with a USD 2.2 million loss. Revenue advanced 3.1% to roughly USD 1.6 billion as operating expenses dipped 2.2%, which means cost control was the engine. Ardent Health, Inc. (NYSE:ARDT) jumped 19.86% in the latest session to USD 15.57. Management nudged the low end of 2026 adjusted EBITDA guidance up to USD 500 million, leaving a USD 535 million ceiling, and set net income guidance at USD 132 million to USD 167 million. A narrower, higher band trims uncertainty, and the shares were recovering from a depressed starting point. Gains stand at 34.69% over 3 months and 57.11% over 6 months. Coverage was split on whether revenue cleared or fell short of estimates, and market value and Volume went unconfirmed. Because the lift is modest and labor costs or payer mix could shift fast, Ardent Health, Inc. (NYSE:ARDT) may reverse.

Acadia Healthcare (NASDAQ:ACHC): Guidance Raised After a Third Quarter Revenue Gain

Acadia Healthcare (NASDAQ:ACHC) rose 12.43% in the session after its 4:05 p.m. ET release on November 4, 2026, reaching USD 36.26 and carrying a 21.51% weekly gain. Sales grew 5.1% to USD 895.3 million, yet adjusted EPS slid to USD 0.60 from USD 0.72, leaving the guidance change to carry the reaction. Full year adjusted EPS now sits at USD 1.70 to USD 1.80, up from USD 1.45 to USD 1.60, and adjusted EBITDA is projected at USD 615 million to USD 625 million. A leveraged operator that raises its outlook can see estimates and valuation rise together, and short covering can add to the jump, which is general context. Shares have gained 47.34% across six months. Leverage is the main risk, with net leverage at 3.9x, Long Term Debt of USD 2,319.9 million and USD 163.3 million of cash. A single session surge can partly reverse, and spreads can be wide for Acadia Healthcare (NASDAQ:ACHC).

Surgery Partners (NASDAQ:SGRY): A USD 23.50 Cash Takeover Caps the Shares

This is a takeover-driven move. HealthSpan Partners agreed on October 26, 2026 to acquire the Business for USD 23.50 per share in cash, a transaction valued at USD 5.7 billion. The stock closed that day at USD 23.25, a 47.62% rise from an earlier close of about USD 15.75 (calculated), on volume of 58.3 million shares against an average near 3.3 million. Cash buyouts reprice the target toward the offer, minus a discount for time and deal risk. Surgery Partners (NASDAQ:SGRY) ended the snapshot at USD 23.16, which leaves a USD 0.34 gap, or about 1.5% (simple arithmetic on two published figures). Bain Capital holds roughly 39% and is reported to back the transaction, with closing expected in the first quarter of 2027. Upside beyond USD 23.50 looks capped, while a delay or failure could push shares back toward roughly USD 15.75 (calculated). With a one week move of negative 0.41%, Surgery Partners (NASDAQ:SGRY) is trading on deal timing rather than on earnings.

Progyny (NASDAQ:PGNY): Third Quarter Profit Beat and Share Count Shrinkage

Third quarter 2026 figures from November 4, 2026 pushed the shares up 13.62% in the latest session to USD 34.20. Adjusted EPS of USD 0.52 topped consensus of USD 0.31, whereas revenue of USD 341.3 million was only about USD 0.49 million ahead of expectations (simple arithmetic), which makes profit the real surprise. Sales rose 8.9% while member growth reached 6.2%. Nearly 3 million shares were bought back for about USD 82.7 million during the quarter, and a smaller share count lifts EPS for any given profit level. Progyny (NASDAQ:PGNY) has climbed 46.22% across six months, so part of the rally predates the report. Published coverage shows a forward P/E of 21.20 and a trailing P/E near 32.72. Employer benefit contracts renew each year, and shifting utilization can alter costs, so Progyny (NASDAQ:PGNY) may give back gains.

Where Things Stand

Surgery Partners posted the largest one month gain at 72.41%, driven by a cash takeover rather than earnings. Earnings and guidance changes explain most of the rest, including Teladoc Health's profit turn, the raised outlooks at Ardent Health and Acadia Healthcare, and Progyny's beat. Taken together, the five names trace back to healthcare services repricing. The list draws on small caps (300 million to 2 billion USD) and mid caps (2 billion to 10 billion USD) across the past week and month, using a market data snapshot from November 5, 2026. Rallies of this magnitude can fade, since a few trades can move a stock and spreads may be wide.